Return on Investment and Cost-Effectiveness of Harm Reduction Program in Malaysia
Cases of human immunodeficiency virus (HIV) infections were first detected in Malaysia in 1986. Since then, the number of new HIV cases has been increasing steadily to a peak of 6,978 new cases detected in 2002 then declining to 3,438 new cases in...
Main Authors: | , , , , , , |
---|---|
Language: | English en_US |
Published: |
Washington, DC
2014
|
Subjects: | |
Online Access: | http://documents.worldbank.org/curated/en/2014/01/19533085/return-investment-cost-effectiveness-harm-reduction-program-malaysia http://hdl.handle.net/10986/18641 |
Summary: | Cases of human immunodeficiency virus
(HIV) infections were first detected in Malaysia in 1986.
Since then, the number of new HIV cases has been increasing
steadily to a peak of 6,978 new cases detected in 2002 then
declining to 3,438 new cases in 2012. In response to the
escalating epidemic, the Government of Malaysia (GOM) agreed
the implementation of needle syringe program (NSP) and
methadone maintenance therapy (MMT) programs against much
public opposition which viewed these programs as being
against the Islamic religion and will encourage more people
to use drugs. The main objectives of this study are to
evaluate whether the harm reduction program in Malaysia is
cost-effective and also whether they provide return on
investments (ROIs) to the government. The study used an
epidemiologic mathematical model of HIV transmission and
disease progression, called the projection and evaluation
tool (Prevtool) developed by a team of investigators at the
Kirby Institute, University of New South Wales, Australia to
simulate the impact of MMT and NSP on the transmission of
HIV among people who inject drugs (PWIDs) in Malaysia.
Briefly, the model simulates the number of PWID who become
infected with HIV over time as well as the extent of disease
progression among those infected in the presence and absence
of harm reduction program in the country. This study has
shown that the combined MMT and NSP programs as implemented
in Malaysia are cost-effective and are expected to produce
net cost-savings to the government in the future. Evidence
of cost-effectiveness and expected cost-savings support
policy recommendation that both MMT and NSP programs should
be maintained as part of the key strategy to control HIV
spread among PWIDs in Malaysia. Study findings that even
with the present program coverage, harm reduction activities
are expected to become more cost-effective and cost-saving
in the future suggest that policies towards program
expansion may demonstrate higher value for money. |
---|